当前位置：
X-MOL 学术
›
Ther. Adva. Endocrinol. Metab.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Screening for MAFLD: who, when and how?
Therapeutic Advances in Endocrinology and Metabolism ( IF 3.8 ) Pub Date : 2023-01-21 , DOI: 10.1177/20420188221145650 Shreya C Pal 1, 2 , Nahum Méndez-Sánchez 1, 3
Therapeutic Advances in Endocrinology and Metabolism ( IF 3.8 ) Pub Date : 2023-01-21 , DOI: 10.1177/20420188221145650 Shreya C Pal 1, 2 , Nahum Méndez-Sánchez 1, 3
Affiliation
Metabolic-associated fatty liver disease (MAFLD) is a highly prevalent disease with increasing prevalence worldwide. Currently, no universal screening methods have been standardized, even when this...
中文翻译：
MAFLD 筛查：谁、何时以及如何筛查？
代谢相关脂肪肝病 (MAFLD) 是一种高度流行的疾病，在全球范围内的患病率不断增加。目前，还没有标准化的通用筛查方法，即使这...
更新日期：2023-01-24
中文翻译：
MAFLD 筛查：谁、何时以及如何筛查？
代谢相关脂肪肝病 (MAFLD) 是一种高度流行的疾病，在全球范围内的患病率不断增加。目前，还没有标准化的通用筛查方法，即使这...
京公网安备 11010802027423号